Patients who experienced a formulary-related rejection of cariprazine for adjunctive treatment of major depressive disorder had significantly higher hospitalization rates than those with approved claims.
Sean D. MacKnight, MScPH
Advertisement
Articles by Sean D. MacKnight, MScPH
Advertisement
Latest Updated Articles
Effects of Adjunctive Cariprazine Formulary Restrictions in Major Depressive DisorderPublished: July 23rd 2025 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
Real-World Data Support Dual Benefit of Biologic Therapy for Hidradenitis Suppurativa
2
Dual JAK Inhibition Demonstrates Efficacy in Progressive Nonsegmental Vitiligo
3
First-in-Class Rocatinlimab Aims to Rebalance T Cells in Atopic Dermatitis: Emma Guttman, MD, PhD
4
ERS Posters Showcase Nerandomilast Benefits in IPF, ILD
5
